RBC Capital Markets

RadNet Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Friday, March 8, 2024

LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a price to the public of $44.00 per share.

Key Points: 
  • LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a price to the public of $44.00 per share.
  • The gross proceeds to RadNet from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $200 million.
  • In addition, RadNet has granted the underwriters a 30-day option to purchase up to an additional 682,500 shares of common stock at the public offering price, less underwriting discounts and commissions.
  • RadNet intends to use the net proceeds from the proposed offering for general corporate purposes and future acquisitions.

ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Retrieved on: 
Thursday, March 7, 2024

The underwriters will have a 30-day option to purchase up to an additional 9,750,000 shares of common stock from the Selling Stockholders.

Key Points: 
  • The underwriters will have a 30-day option to purchase up to an additional 9,750,000 shares of common stock from the Selling Stockholders.
  • The Company is not selling any shares and will not receive any proceeds from the offering.
  • In addition, ADT has authorized the concurrent purchase from the underwriters of 15,000,000 shares of common stock as part of the secondary public offering (the “Share Repurchase”) subject to the completion of the offering.
  • The Share Repurchase is part of the Company’s existing $350 million share repurchase program.

ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Retrieved on: 
Wednesday, March 6, 2024

The underwriters will have a 30-day option to purchase up to an additional 8,250,000 shares of common stock from the Selling Stockholders.

Key Points: 
  • The underwriters will have a 30-day option to purchase up to an additional 8,250,000 shares of common stock from the Selling Stockholders.
  • The Company is not selling any shares and will not receive any proceeds from the proposed offering.
  • In addition, ADT has authorized the concurrent purchase from the underwriters of 15,000,000 shares of common stock as part of the secondary public offering (the “Share Repurchase”) subject to the completion of the offering.
  • The Share Repurchase is part of the Company’s existing $350 million share repurchase program.

Athene Prices $500 Million Investment Grade Junior Subordinated Debentures Offering

Retrieved on: 
Friday, March 1, 2024

WEST DES MOINES, Iowa, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”) today announced it has agreed to sell $500 million aggregate principal amount of 7.250% fixed-rate reset junior subordinated debentures due 2064 and to grant the underwriters an option, exercisable for 30 days, to purchase up to an additional $75 million aggregate principal amount of debentures solely to cover over-allotments.

Key Points: 
  • WEST DES MOINES, Iowa, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”) today announced it has agreed to sell $500 million aggregate principal amount of 7.250% fixed-rate reset junior subordinated debentures due 2064 and to grant the underwriters an option, exercisable for 30 days, to purchase up to an additional $75 million aggregate principal amount of debentures solely to cover over-allotments.
  • The offering is expected to close on March 7, 2024, subject to satisfaction of customary closing conditions.
  • Wells Fargo Securities, BofA Securities, J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering.
  • The debentures are being offered pursuant to an effective shelf registration statement that has previously been filed with the Securities and Exchange Commission (the “SEC”).

First Advantage to Acquire Sterling Check Corp. for $2.2 Billion in Cash and Stock

Retrieved on: 
Thursday, February 29, 2024

First Advantage will issue a combination of cash and stock valuing Sterling at approximately $2.2 billion, including Sterling’s outstanding debt.

Key Points: 
  • First Advantage will issue a combination of cash and stock valuing Sterling at approximately $2.2 billion, including Sterling’s outstanding debt.
  • First Advantage will share additional forward-looking financial information regarding the transaction’s impact at or around the time of closing.
  • The transaction consideration is comprised of approximately $1.2 billion in cash and 27.15 million shares of First Advantage common stock.
  • Under the terms of the agreement, Sterling shareholders will elect to receive either $16.73 in cash or 0.979 shares of First Advantage common stock for each Sterling share.

Tyson Foods, Inc. Announces Pricing of Senior Notes Offerings

Retrieved on: 
Thursday, February 29, 2024

SPRINGDALE, Ark., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (the “Company”) (NYSE: TSN) announced today that it has agreed to sell $600 million aggregate principal amount of its 5.400% Senior Notes due 2029 (the “2029 notes”) and $900 million aggregate principal amount of its 5.700% Senior Notes due 2034 (the “2034 notes”) in underwritten public offerings under its effective shelf registration statement.

Key Points: 
  • SPRINGDALE, Ark., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (the “Company”) (NYSE: TSN) announced today that it has agreed to sell $600 million aggregate principal amount of its 5.400% Senior Notes due 2029 (the “2029 notes”) and $900 million aggregate principal amount of its 5.700% Senior Notes due 2034 (the “2034 notes”) in underwritten public offerings under its effective shelf registration statement.
  • The offerings are expected to close on March 8, 2024, subject to the satisfaction of customary closing conditions.
  • The company intends to use the net proceeds from the offerings for general corporate purposes, which is expected to include the retirement of the outstanding 3.95% Notes due August 2024 (the ‘‘2024 Notes’’).
  • Barclays Capital Inc. and Goldman Sachs & Co. LLC are acting as senior co-managers for the offerings.

Sotera Health Announces Pricing of Secondary Offering

Retrieved on: 
Wednesday, February 28, 2024

CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share.

Key Points: 
  • CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share.
  • The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering.
  • The Company has agreed to pay certain Offering expenses consistent with its obligations under its Amended and Restated Registration Rights Agreement.
  • Barclays, RBC Capital Markets and Santander US Capital Markets LLC are acting as joint book-running managers for the Offering.

Old National Bancorp to Present at the 2024 RBC Capital Markets Financial Institutions Conference

Retrieved on: 
Wednesday, February 28, 2024

EVANSVILLE, Ind., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Old National Bancorp (NASDAQ: ONB) today announced that Chairman and Chief Executive Officer Jim Ryan will be presenting at the 2024 RBC Capital Markets Financial Institutions Conference on Tuesday, March 5, 2024, at 11:20 a.m. Eastern Time.

Key Points: 
  • EVANSVILLE, Ind., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Old National Bancorp (NASDAQ: ONB) today announced that Chairman and Chief Executive Officer Jim Ryan will be presenting at the 2024 RBC Capital Markets Financial Institutions Conference on Tuesday, March 5, 2024, at 11:20 a.m. Eastern Time.
  • Interested investors may listen to the live webcast of the event by accessing the Investor Relations section at oldnational.com .
  • For those unable to attend the live broadcast, a replay of the webcast will be made available on the same site.

Colliers International Group Inc. Completes US$300 Million Bought Deal Public Offering of Equity

Retrieved on: 
Wednesday, February 28, 2024

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX and NASDAQ: CIGI) (“Colliers” or the “Company”) is pleased to report that it has closed its previously announced bought deal public offering of 2,479,500 subordinate voting shares (the “Subordinate Voting Shares”), at a price of US$121.00 per Subordinate Voting Share for gross proceeds of US$300.0 million (the “Offering”) with a syndicate of underwriters led by BMO Capital Markets and J.P. Morgan as joint bookrunners, and including Mizuho, National Bank Financial, RBC Capital Markets, Scotiabank, Merrill Lynch, BTIG, LLC, CIBC Capital Markets, Goldman Sachs, Raymond James, TD Securities, Wells Fargo and Stifel Nicolaus (the “Underwriters”).

Key Points: 
  • TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX and NASDAQ: CIGI) (“Colliers” or the “Company”) is pleased to report that it has closed its previously announced bought deal public offering of 2,479,500 subordinate voting shares (the “Subordinate Voting Shares”), at a price of US$121.00 per Subordinate Voting Share for gross proceeds of US$300.0 million (the “Offering”) with a syndicate of underwriters led by BMO Capital Markets and J.P. Morgan as joint bookrunners, and including Mizuho, National Bank Financial, RBC Capital Markets, Scotiabank, Merrill Lynch, BTIG, LLC, CIBC Capital Markets, Goldman Sachs, Raymond James, TD Securities, Wells Fargo and Stifel Nicolaus (the “Underwriters”).
  • Colliers has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any.
  • The net proceeds of the Offering will be used to repay balances outstanding on the Company’s credit facility and are intended to create additional capacity to fund potential future acquisition opportunities and growth initiatives, and for general corporate purposes.
  • No securities regulatory authority has either approved or disapproved of the contents of this news release.

Applied Therapeutics Announces $100 Million Private Placement

Retrieved on: 
Wednesday, February 28, 2024

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it has entered into a securities purchase agreement for a private placement of $100 million of equity.

Key Points: 
  • The Private Placement is expected to result in gross proceeds to the Company of approximately $100 million, before deducting placement agent commissions and other offering expenses.
  • The Private Placement is expected to close on or about March 1, 2024, subject to the satisfaction of customary closing conditions.
  • Additional details regarding the Private Placement will be included in a Form 8-K to be filed by the Company with the Securities and Exchange Commission (“SEC”).
  • Leerink Partners, RBC Capital Markets, Baird, and UBS Investment Bank acted as placement agents in the transaction (the “Placement Agents”).